I found Jack Haddad over on Myspace.com. He is a very savvy / investor trader. I have set up this thread for him to post his ideas on. Go for it Jack, and welcome!
Doctor Jack's Stock Medicine
Collapse
X
-
Originally posted by mrmarketI found Jack Haddad over on Myspace.com. He is a very savvy / investor trader. I have set up this thread for him to post his ideas on. Go for it Jack, and welcome!
WelcomeHide not your talents.
They for use were made.
What's a sundial in the shade?
- Benjamin Franklin
-
-
Originally posted by peanutsAn endorsement from the HUGE one.... I will look forward to gaining knowledge and $$$$ from the upcoming advice
Welcome
Though I'm primarily a market technician, I do believe that a company's fundamentals play a role in disciplined trading. For further review of this topic and technical versus fundamental analysis, please see my article at: http://falkincommunity.blogspot.com/...t-writing.html
All the best,
Jack Haddad, MD, MBA, CMT
Comment
-
-
Tso
Free US and Canadian stock technical analysis, charts and stock screening tool utilizing technical analysis techniques such as candlestick charting, fibonacci projections, volume analysis, gaps, trends, RSI, MACD, and Stochastics.
The above 6-month chart on TSO is very interesting. Note the inverse head-and-shoulder pattern which spanned from Feb 15 to March 8. This has cuased the stock to propel to a a 52 week high of 75. Thereafter, the stock has recently trended down to test the intermediate term support of 65, but was noty successful in breaching the 6 months support of 60.75.
At this hour, the stock has gained strength on the hourly...and since horizontal support stands a good support at 62.50, I did the following: Purchased shares at 65.40, and wrote the June 65 strike calls for 2.85/contract. I feel this strategy provides a good hedge for the time being. I will update all changes/executions later.
Comment
-
-
Welcome
Welcome, Dr. Jack! I will also be looking forward to your analyses. I'm particularly interested by the fact that you posted (in the other thread) about ImClone. IMCL is a stock that I am currently holding a long position on, as well as some June $40 calls. While I'm more of a fundamental-type, I do like to examine technical trends/patterns as well.
ImClone has a very real catalyst looming on the horizon right now. The annual meeting of the American Society of Clinical Oncology (ASCO) is scheduled to take place the first week in June, where the results of several key clinical studies are going to be released. From my limited understanding of these things, I'm inclined to believe there are going to be some positive results unveiled there that will be seen as fuel for growth in Erbitux sales--not the least of which is one that may indicate some inroads into Avastin's market share in 1st line metastatic colorectal cancer. Other types of cancer for which Erbitux may prove effective include non-small-cell lung (the biggie) and pancreatic.
Even most technical traders will agree that news trumps charts every time. Well there is news soon to break here.—Rob
Comment
-
-
The above 6-month chart on TSO is very interesting. Note the inverse head-and-shoulder pattern which spanned from Feb 15 to March 8.
With TSO there was no pattern to volume in that time period. In fact, volume was very light near the top of the right shoulder.
Comment
-
-
Originally posted by RobWelcome, Dr. Jack! I will also be looking forward to your analyses. I'm particularly interested by the fact that you posted (in the other thread) about ImClone. IMCL is a stock that I am currently holding a long position on, as well as some June $40 calls. While I'm more of a fundamental-type, I do like to examine technical trends/patterns as well.
ImClone has a very real catalyst looming on the horizon right now. The annual meeting of the American Society of Clinical Oncology (ASCO) is scheduled to take place the first week in June, where the results of several key clinical studies are going to be released. From my limited understanding of these things, I'm inclined to believe there are going to be some positive results unveiled there that will be seen as fuel for growth in Erbitux sales--not the least of which is one that may indicate some inroads into Avastin's market share in 1st line metastatic colorectal cancer. Other types of cancer for which Erbitux may prove effective include non-small-cell lung (the biggie) and pancreatic.
Even most technical traders will agree that news trumps charts every time. Well there is news soon to break here.
Comment
-
-
Originally posted by DStecklerThat's a continuation H&S, not an inverse H&S. The difference is: 1) the former is a consolidation or continuation formation whereas the latter is a reversal formation; and 2) volume in the former follows no pattern whereas in the latter, the left shoulder sees the lightest volume and volume gets higher as the pattern unfolds, with the heaviest volume in the right shoulder.
With TSO there was no pattern to volume in that time period. In fact, volume was very light near the top of the right shoulder.
Comment
-
-
It's A Good Thing
Originally posted by mrmarketDoes Martha Stewart still own shares of Imclone?
Edit: just read the article. Good stuff, Jack!Last edited by Rob; 05-25-2006, 02:58 PM.—Rob
Comment
-
Comment